Sachi Horibata, Ph.D. is an Assistant Professor in the Precision Health Program and the Department of Pharmacology and Toxicology. Dr. Horibata’s research focuses on cancer drug resistance mechanisms and identification of therapeutic targets for personalized cancer treatments.
Dr. Horibata earned her Ph.D. in Pharmacology from Cornell University. She completed her postdoctoral training at the National Cancer Institute, where she was awarded the Sallie Rosen Kaplan Postdoctoral Fellowship for Women Scientists. She joined MSU in fall 2021.
Dr. Horibata uses genomics approaches to dissect the unique transcriptomic profiles of individual patients and identify optimal treatment regimens for personalized therapy. Her research goals are driven by questions concerning how cancer progresses, why it develops resistance to drug treatments, and what we can do to improve outcomes in patient care. Currently, her lab works on understanding the development and evolution of cancer drug resistance and identification of therapeutic targets.